Cancer Prevention and Control Clinical Trials Planning Grant Program (U34, Clinical Trials Optional) – PAR-25-103

The National Cancer Institute (NCI) intends to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors

Reference

KIPRE-2026-006

Funding Agency

National Cancer Institute (NIH)

Amount

Up to US$225,000/year; US$450,000 total over 3 years (US$600,000 with a pilot trial)

Closes

25 October 2026

Link

View source